(19)
(11) EP 4 511 016 A1

(12)

(43) Date of publication:
26.02.2025 Bulletin 2025/09

(21) Application number: 23722968.7

(22) Date of filing: 21.04.2023
(51) International Patent Classification (IPC): 
A61K 31/164(2006.01)
A23L 33/105(2016.01)
A61P 19/10(2006.01)
 A61K 36/11(2006.01)
A23L 33/12(2016.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/164; A23L 33/105; A23L 33/12; A61P 19/10; A61K 36/11; A61K 9/48
 
C-Sets:
  1. A61K 31/164, A61K 2300/00;
  2. A61K 36/11, A61K 2300/00;
(86) International application number:
PCT/IB2023/054087
(87) International publication number:
WO 2023/203531 (26.10.2023 Gazette 2023/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.04.2022 IT 202200008066

(71) Applicant: Agave S.r.l.
59100 Prato (IT)

(72) Inventor:
  • UBERTI, Francesca
    21012 Cassano Magnago (VA) (IT)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners Via Meravigli, 16
20123 Milano
20123 Milano (IT)

   


(54) COMBINATION OF PALMITOYLETHANOLAMIDE AND EQUISETUM, FOOD, NUTRACEUTICAL AND/OR PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE THEREOF IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS